» Articles » PMID: 12567863

[Structures and Pharmacological Activities of Beesiosides O and P]

Overview
Journal Yao Xue Xue Bao
Specialties Pharmacology
Pharmacy
Date 2003 Feb 6
PMID 12567863
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the chemical constituents of the rhizomes of Beesia calthaefolia native to China in order to obtain a more comprehensive understanding of its effective components.

Methods: Compounds were isolated by column chromatography with silica gel. Their structures were elucidated by spectral analysis and chemical evidence. Compounds identified were subjected to pharmacological evaluation.

Results: Two novel compounds were isolated and identified as (20S, 24S)-15 alpha-acetoxy-16 beta, 24; 20, 24-diepoxy-9, 19-cyclolanostane-3 beta, 25-diol-3-O-beta-D-xylopyranoside (I) and (20S, 24R)-15 alpha-acetoxy-9, 19-cyclolanostane-3 beta, 16 beta, 20, 24, 25-pentaol-3-O-beta-D-xylopyranoside (II), named beesioside O and beesioside P.

Conclusion: Compounds I and II are new compounds. Compounds I exhibited immunosuppressive activity and could inhibit angiogenesis as well as inhibit the proliferation of osteoblast. Compound II displayed remarkable inhibition activity against calcium channel receptor.

Citing Articles

Revealing the Role of Beesioside O from for the Treatment of Breast Cancer Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.

Li S, Lu J, Xue H, Lou Y, Liu J, Wang Y Int J Mol Sci. 2025; 26(5).

PMID: 40076902 PMC: 11899959. DOI: 10.3390/ijms26052283.


Cycloartane-type triterpene glycosides from Beesia calthaefolia and their anticomplement activity.

Mu L, Li H, Guo D, Zhao J, Liu P J Nat Med. 2014; 68(3):604-9.

PMID: 24535721 DOI: 10.1007/s11418-014-0820-5.


Effects of (20S*,24R*)-epoxy-9,19-cyclolanstane-3β,12β,16β,25-pentaol-3-O-β-D-xylopyranoside extracted from rhizoma Beesia on immunoregulation and anti-inflammation.

Dong X, Guo D, Liu P, Mu L, Ge X, Li H Inflammation. 2014; 37(1):277-86.

PMID: 24458351 DOI: 10.1007/s10753-013-9738-4.